Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.6 (
thromboplastin
)
13,278
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Isolation of six calcium-binding proteins from human placenta is described by means of hydrophobic chromatography, calcium-dependent adsorption to heparin-Sepharose and ion-exchange chromatography. These proteins were characterized and identified as PP4,
PP4-X
, PAP III, p68 and lipocortins I and II belonging to the family of annexins. Antibodies raised against PP4, PAP III and p68 revealed to be highly specific, while those raised against
PP4-X
reacted with all investigated annexins, except PP4. Cross-reactivity was also observed between lipocortins I and II. All annexins inhibited in a concentration-dependent manner blood coagulation but with different potencies as was determined by means of a modified
thromboplastin
time test. The most potent inhibitors turned out to be PP4 and PAP III, followed by
PP4-X
, lipocortin I, p68 and lipocortin II.
...
PMID:Purification and characterization of six annexins from human placenta. 214 74
The human placental proteins PP4 and
PP4-X
, belonging to the annexin protein family, were expressed in Escherichia coli at high yield. The proteins were purified to homogeneity. The physicochemical parameters of the recombinant proteins were determined and compared with those of their natural placental counterparts. Except for a minor change in the pI, the proteins appeared to be indistinguishable by several criteria. Both recombinant PP4 and recombinant
PP4-X
were biologically active in a
thromboplastin
inhibition test and in a phospholipase A2 inhibition test.
...
PMID:Annexin proteins PP4 and PP4-X. Comparative characterization of biological activities of placental and recombinant proteins. 214 60
A cDNA library prepared from human placenta was screened for sequences encoding the placental protein 4 (PP4). PP4 is an anticoagulant protein that acts as an indirect inhibitor of the
thromboplastin
-specific complex, which is involved in the blood coagulation cascade. Partial amino acid sequence information from PP4-derived cyanogen bromide fragments was used to design three oligonucleotide probes for screening the library. From 10(6)independent recombinants, 18 clones were identified that hybridized to all three probes. These 18 recombinants contained cDNA inserts encoding a protein of 320 amino acid residues. In addition to the PP4 cDNA we identified 9 other recombinants encoding a protein with considerable similarity (74%) TO PP4, which was termed
PP4-X
. PP4 and
PP4-X
belong to the lipocortin family, as judged by their homology to lipocortin I and calpactin I.
...
PMID:Characterization of cDNA encoding human placental anticoagulant protein (PP4): homology with the lipocortin family. 296 95
The placental protein PP41,2 was shown to have
thromboplastin
-inhibitor activity. We used partial amino acid sequence information from PP4 cyanogen bromide fragments to design oligonucleotide probes for the screening of a human placental cDNA library. In addition to the PP4 cDNA we isolated a cDNA coding for a protein with considerable homology which we subsequently termed
PP4-X
. PP4 and
PP4-X
belong to the phospholipase A2 inhibitor family, as judged by their homology to lipocortin I and calpactin I3. The full-length
PP4-X
cDNA encodes a protein of 321 amino acid residues including a fourfold repeat structure. Northern blot analysis using the
PP4-X
cDNA reveals two hybridizing RNA species of approximately 1400 nucleotides and 2500 nucleotides, respectively. The shorter one could well represent the
PP4-X
transcript which is in good agreement with the isolated cDNA insert of 1326 nucleotides. Expression of the
PP4-X
coding sequence in E. coli resulted in the appearance of a protein which crossreacts with antibodies raised against PP4.
...
PMID:Isolation and expression of cDNA coding for a new member of the phospholipase A2 inhibitor family. 297 Feb 57